Medicine
Showing 2,301-2,400 of 2,408 Results
-
Joseph C. Wu, MD, PhD
Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology
Current Research and Scholarly InterestsDrug discovery, drug screening, and disease modeling using iPSC.
-
Joy Wu
Gerald M. Reaven, MD Professor of Endocrinology
Current Research and Scholarly InterestsMy laboratory focuses on the pathways that regulate the differentiation of mesenchymal stem cells into the osteoblast and adipocyte lineages. We are also studying the role of osteoblasts in the hematopoietic and cancer niches in the bone marrow microenvironment.
-
Sean M. Wu
Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMy lab seeks to identify mechanisms regulating cardiac lineage commitment during embryonic development and the biology of cardiac progenitor cells in development and disease. We believe that by understanding the transcriptional and epigenetic basis of cardiomyocyte growth and differentiation, we can identify the most effective ways to repair diseased adult hearts. We employ mouse and human embryonic and induced pluripotent stem cells as well as rodents as our in vivo models for investigation.
-
Allen Wu
Principal Engineer At Eli Lilly And Company, Medicine - Med/Cardiovascular Medicine
BioAllen Wu is a machine learning engineer and researcher specializing in large-scale AI/ML infrastructure for biomedical and pharmaceutical applications. He contributed to the development of TuneLab, an Eli Lilly AI/ML platform supporting federated drug discovery with external biotech partners, and Model Gateway, an MLOps inference platform for internal model-driven drug discovery, during his tenure at Eli Lilly. He holds dual MS degrees in Computer Science (National Chiao Tung University, Taiwan) and Software Engineering (San José State University), with publications in both VLSI/EDA and Pharma AI, and is an IEEE peer reviewer and NSTC LEAP Fellow (hosted at Synopsys). His current research interests focus on the intersection of iPSC biology and AI/ML pipelines for precision medicine.
LinkedIn Profile: https://www.linkedin.com/in/yswu123
Google Scholar Profile: https://scholar.google.com/citations?user=ymttL5gAAAAJ -
Min Xie
Postdoctoral Fellow, Medicine - Primary Care and Population Health
BioCausal inference using natural experiments with focuses on public health policy and medical intervention.
Also work on development economics topics of financial and education intervention.
PhD in economics, Heidelberg University
personal webpage: https://minxie.org -
Xiaojing Xing
Masters Student in Clinical Informatics Management, admitted Summer 2025
BioXiaojing Xing is a health tech founder and product leader working at the intersection of medicine, business, and technology. She has driven AI-powered innovations across hardware and software—building from MVP to scale at both startups and global tech companies.
At Tencent, she led digital health platforms serving over 30 million users and launched AI tools that empowered 200,000+ physicians. Later, as Chief Product Officer at MindLax, she brought a neurofeedback sleep device from concept to market, growing it to thousands of users through data-driven iteration and user empathy.
Recognized on Forbes 30 Under 30 China, Xiaojing blends product management, global go-to-market strategy, and health innovation expertise. She is currently focused on applying AI to consumer health—creating intelligent, accessible technologies that make wellbeing part of everyday life.
Xiaojing holds degrees from Stanford University School of Medicine, Harvard T.H. Chan School of Public Health, and Peking University Health Science Center. -
Eitan Yaffe
Affiliate, Medicine - Med/Infectious Diseases
BioDr. Eitan Yaffe is a computational biologist studying the evolution of natural microbial communities under selective pressures, such as antibiotics. He is currently a research associate in the lab of Dr. David Relman at Stanford University, where he develops experimental and computational approaches to investigate strain dynamics, horizontal gene transfer, and the emergence of antimicrobial resistance in the human microbiome.
Dr. Yaffe holds a PhD in Computer Science from the Weizmann Institute of Science, where he focused on epigenetics and chromatin folding. He earned his MSc in Computer Science with a specialization in the 3D structure of protein channels, and his BSc in Mathematics and Computer Science from the Hebrew University of Jerusalem. -
Natsuhiko Yamada
Affiliate, Medicine - Med/Family and Community Medicine
BioNatsuhiko Yamada is a pediatrician and AI researcher at National Center for Child Health and Development (NCCHD), Japan. As a clinician, he cares for critically ill pediatric patients referred and transported from across Japan, and has reported a novel genetic mutation in hematologic disease. At NCCHD Research Institute, he serves as Principal Investigator, leading AI predictive modeling research using real-world clinical data in collaboration with Japan Institute for Health Security.
He is also pursuing a Master of Public Health at Johns Hopkins Bloomberg School of Public Health. He has contributed to global burden of disease studies with researchers across the globe. Previously, at Institute of Science Tokyo, he published on cancer metabolism and was awarded a WILEY Top Cited Article. In 2026, he was selected as a Stanford CARE Scholar at Stanford University School of Medicine.
Beyond research, he has demonstrated strong global health leadership. As Project Lead at the World Economic Forum Global Shapers Community, he led policy proposals for Okinawa Prefecture, the poorest prefecture facing a health crisis in Japan. He collaborated with Okinawa Medical, Nursing, Dental, and Pharmaceutical Associations and professors across Japan, and potentially impacted an estimated 1.5 million residents. He also served on the Committee for Shaping a New World at Expo 2025 Osaka, Kansai, Japan, moderating a flagship session to redefine the future of mental health in 2050.
He envisions a world where every child and every person can enjoy sound health, regardless of where they are born or live, at the intersection of clinical medicine, molecular biology, public health, and artificial intelligence. -
Phillip C. Yang, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Yang is a physician-scientist whose research interest focuses on clinical translation of the fundamental molecular and cellular processes of myocardial restoration. His research employs novel in vivo multi-modality molecular and cellular imaging technology to translate the basic innovation in cardiovascular pluripotent stem cell biologics. Dr. Yang is currently a PI on the NIH/NHLBI funded CCTRN UM1 grant, which is designed to conduct multi-center clinical trial on novel biological therapy.
-
Zhiyu Yang, MD
Affiliate, Medicine - Med/Gastroenterology and Hepatology
Visiting Scholar, Medicine - Med/Gastroenterology and HepatologyBioAs a clinical physician specializing in gastroenterology and hepatology, I am proficient in the clinical diagnosis and treatment of common gastrointestinal diseases and various liver diseases. My main research lay on metabolic related liver diseases and inflammatory bowel diseases.
-
Seema Yasmin
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioSeema Yasmin is an Emmy Award-winning journalist, poet, medical doctor and author. Yasmin served as an officer in the Epidemic Intelligence Service at the U.S. Centers for Disease Control and Prevention where she investigated disease outbreaks and was principal investigator on a number of CDC studies. Yasmin trained in journalism at the University of Toronto and in medicine at the University of Cambridge.
Yasmin was a finalist for the Pulitzer Prize in breaking news in 2017 with a team from The Dallas Morning News for coverage of a mass shooting, and recipient of an Emmy award for her reporting on neglected tropical diseases and their impact on resource poor communities in the U.S. She received multiple grants from the Pulitzer Center on Crisis Reporting for coverage of gender based violence in India and the aftermath of the Ebola epidemic in West Africa. In 2017, Yasmin was a John S. Knight Fellow in Journalism at Stanford University investigating the spread of health misinformation and disinformation during public health crises. Previously she was a science correspondent at The Dallas Morning News, medical analyst for CNN, and professor of public health at the University of Texas at Dallas. She teaches crisis management and crisis communication at the UCLA Anderson School of Management as a Visiting Assistant Professor.
She is the author of 12 non-fiction, fiction, poetry and childrens books, including: Can Scientists Succeed Where Politicians Fail? (Johns Hopkins University Press, 2025) which was co-authored with Nobel laureate Dr. Peter Agre; What the Fact?! Finding the Truth in All the Noise (Simon and Schuster, 2022); Viral BS: Medical Myths and Why We Fall For Them (Johns Hopkins University Press, 2021); Muslim Women Are Everything: Stereotype-Shattering Stories of Courage, Inspiration and Adventure (HarperCollins, 2020); If God Is A Virus: Poems (Haymarket, 2021); Unbecoming: A Novel (Simon and Schuster, 2024); Djinnology: An Illuminated Compendium of Spirits and Stories from the Muslim World (Chronicle, 2024); and The ABCs of Queer History (Workman Books, 2024). Her writing appears in The New York Times, Rolling Stone, WIRED, Scientific American and other outlets.
Yasmin’s unique expertise in epidemics and communications has been called upon by the Vatican, the Presidential Commission for the Study of Bioethical Issues, the Aspen Institute, the Skoll Foundation, the Biden White House, and others. She teaches a new paradigm for trust-building and evidence-based communication to leadership at the World Health Organization and CDC. In 2019, she was the inaugural director of the Stanford Health Communication Initiative.
Her scholarly work focuses on the spread of scientific misinformation and disinformation, information equity, and the varied susceptibilities of different populations to false information about health and science. In 2020, she received a fellowship from the Emerson Collective for her work on inequitable access to health information. She teaches multimedia storytelling to medical students in the REACH program. -
Emmanuelle Yecies, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Emmanuelle Yecies is a board-certified internal medicine doctor at Stanford Health Care, with fellowship training in women’s health and medical education. She is also a clinical assistant professor in the Department of Medicine, Division of Primary Care and Population Health at Stanford University School of Medicine.
Dr. Yecies practices comprehensive primary care and preventive care. Her additional training in women’s health equips her with the skills to manage complex, gender-specific health needs throughout the lifespan, including hormone management, reproductive health care, and chronic disease management. She provides comprehensive, trauma-informed care that’s personalized to each of her patients.
Dr. Yecies’ research interests include preventive care and comprehensive chronic disease management for women in different reproductive stages of life, from menstruation through menopause. As a clinician educator, she has developed numerous educational materials for trainees and faculty. She is a frequent lecturer on issues affecting women’s health, both locally and nationally.
Dr. Yecies has published her work in peer-reviewed journals, such as Journal of General Internal Medicine, Seminars in Reproductive Medicine, Southern Medical Journal, and BMJ Open. She has authored chapters in medical textbooks and has also presented at national and regional meetings, including annual meetings of the Society of General Internal Medicine (SGIM) and the Alliance for Academic Internal Medicine (AAIM).
Dr. Yecies is a member of SGIM. -
Gwen Yeo
Sr Research Scholar, Medicine - Family & Community Medicine
Current Research and Scholarly InterestsEthnicity and Dementia
Ethnogeriatric Education
Ethnogeriatric Care -
Alan Yeung, MD
Li Ka Shing Professor in Cardiology
Current Research and Scholarly InterestsCoronary artery disease is the leading cause of death in men and women in the United States. Our group is interested in studying both the early and late phases of atherosclerosis so that we can better develop prevention and treatment strategies.
-
Celina Yong, MD, MBA, MSc
Associate Professor of Medicine (Cardiovascular Medicine)
BioCelina Yong, MD, MBA, MSc, FACC, FAHA, FSCAI, is an Associate Professor in the Stanford School of Medicine and Director of Interventional Cardiology at the VA Palo Alto Medical Center. Dr. Yong leads an active health services research lab focused on using large database analyses and novel scalable approaches to improve the quality of cardiovascular care. In her clinical practice, Dr. Yong performs complex percutaneous coronary interventions and transcatheter aortic valve replacements. She is actively involved in clinical trials of novel device and drug therapies for cardiovascular disease. She serves as an Associate Editor for the Journal of the American College of Cardiology and leads the VA-Cardiovascular Trials Consortium.
Prior to joining the Stanford faculty, Dr. Yong completed an MSc in Health Policy, Planning and Financing from the London School of Economics and MBA from Oxford as a Marshall Scholar. She completed her MD at Stanford, internal medicine residency at UCSF, and cardiology and interventional cardiology fellowships at Stanford. -
Shady Younis
Instructor, Medicine - Immunology & Rheumatology
BioShady Younis, PhD is an instructor at the division of Immunology and Rheumatology at Stanford University. He received his PhD in Medical Sciences from Uppsala University in Sweden. He later joined Dr. William Robinson’s Lab at Stanford University as Wallenberg postdoctoral fellow, where he characterized the pathogenic role of cytotoxic CD8+ T cells in rheumatoid arthritis. His current research aimed at elucidating the underlying triggers of pathogenic B cell responses in a spectrum of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS). He uses computational methodologies alongside cutting-edge high-throughput sequencing technologies to characterize the autoreactive B and T cells. The overarching research objective of his research is to unravel the mechanistic roles of Epstein-Barr Virus (EBV) reactivation in activating and transforming autoreactive B cells in the development of autoimmunity.
-
Grace Chen Yu
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Yu is a modern-day version of the “old-fashioned family doc” who delights in caring for patients from “cradle to grave,” while also promoting the health of her community and developing the future leaders of family medicine. On any particular day, one might find her counseling a long-time smoker on quitting, draining an abscess in clinic, delivering a baby, doing a phone (or sometimes home) visit with one of her elderly patients, lecturing about High-Value Health Care, facilitating a diabetes group visit, singing the praises of coordinated primary care to politicians, discussing end-of-life options with a hospitalized patient, or sharing some of her stories as mother-doctor-teacher with one of her advisees. In 2016, adding one more hat to the mix, Dr. Yu became Program Director of the 24-resident Stanford Health Care - O’Connor Hospital Family Medicine Residency Program. Whereas the old-fashioned family doc was a master at caring for patients at different ages and stages of life, as a modern-day family physician, Dr. Yu is committed to researching ways to do so more effectively and efficiently. She considers it a privilege to be a part of her patients' lives and hopes to help both her patients and her trainees find a path to better health and happiness. To keep herself in great health, Dr. Yu enjoys playing the piano, photography, scuba diving, adventure travel (all the more adventurous with her three children in tow!), and spending time with her family and friends.
-
Ilana Rachel Yurkiewicz
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Ilana Yurkiewicz is a Clinical Associate Professor of Medicine at Stanford University School of Medicine in the Division of Primary Care and Population Health and Division of Oncology (by courtesy). Board certified in internal medicine, hematology, and oncology, she co-directs Stanford’s Primary Care for Cancer Survivorship Program, an innovative clinic that cares for cancer survivors and patients at elevated risk. She is also an award-winning medical journalist and Stanford’s inaugural Physician-Journalist in Residence.
Her academic and clinical work centers on developing new models of care that bridge oncology and primary care. She has built programs to provide coordinated, longitudinal care for patients during and after cancer treatment and those with inherited cancer predispositions.
As a physician-journalist, she is the author of the nationally acclaimed book Fragmented: A Doctor’s Quest to Piece Together American Health Care (W.W. Norton, 2023). Her writing has also appeared in The Best American Science and Nature Writing, The Atlantic, Scientific American, TIME, STAT, Undark, and other outlets. She received a Folio Award for best healthcare column and was shortlisted for the Cancer Journalism Award.
She is Faculty Director of the annual Big Ideas in Medicine conference, which convenes leaders across fields to examine pressing challenges in health and society. She advises startups focused on cancer survivorship and prevention. As Associate Medical Director of Stanford’s Internal Medicine Clinic, she oversees the largest primary care clinic for Stanford residents. She teaches core concepts of cancer survivorship and primary care to residents, medical students, fellows, and faculty.
Her research focuses on designing new approaches to cancer survivorship delivery, and she leads a research team evaluating their implementation in practice. Her work has been published in the New England Journal of Medicine, Journal of Clinical Oncology, Genetics in Medicine, and other peer-reviewed journals. She has presented nationally at meetings including the Society of General Internal Medicine, American Society of Hematology, and National Society of Genetic Counselors. She has also served on the editorial board of Hematology News.
Earlier in her career, Dr. Yurkiewicz interned with the Presidential Commission for the Study of Bioethical Issues and contributed to white papers on ethical challenges in medicine. She is a member of the American College of Physicians and an associate member of the American Society of Clinical Oncology and American Society of Hematology. -
Roham Zamanian
James and Yvonne Wood Professor of Pulmonary Vascular Medicine
Current Research and Scholarly Interests1. Development and evaluation of prognostic and diagnostic integral biomarkers in PAH.
2. Prevalence and Treatment of Insulin Resistance in PAH.
3. Role of inflammation and proteomic signature in PAH
4. Development of novel therapeutics (bench to bedside) including FK506 & Elastase Inhibition in PAH.
5. Assessment of Vasoreactivity (gain and loss) in pulmonary arterial hypertension
6. Assessment of microvascular function in PAH. -
James L. Zehnder, M.D.
Professor of Pathology (Research) and of Medicine (Hematology)
Current Research and Scholarly InterestsMy main research and clinical interests include molecular pathogenesis of acquired cytopenias, genetic testing for inherited non-malignant hematologic disorders, next-generation sequencing approaches to T and B cell clonality testing, somatic mutations in cancer and assessment of minimal residual disease in cancer patients.
-
Mira Zein
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Associate Professor (By courtesy), Medicine - Primary Care and Population HealthBioDr. Zein received her dual bachelor’s degrees in Anthropology and Physiological Science at UCLA and worked initially as a healthcare consultant, developing programs that improve healthcare access for vulnerable populations. She returned to school to pursue a Masters in Public Health at Johns Hopkins University; her research foci were disaster response interventions for physical and mental health and the impact of the built environment on public health. During her masters, she worked with the International Rescue Committee in Baltimore to help address the acculturation and psychological stress the Baltimore refugee population faced in resettlement.
Dr. Zein completed her medical training at McGill University. During medical school she continue to pursue interests in global and cultural health, focusing on national and local clinical projects to support refugee and asylum seeker access to medical and mental health treatment as part of CFMS. She was awarded the Mona Bronfman Sheckman Prize in Psychiatry for her work. During her psychiatry residency training at New York University (NYU), Dr. Zein continued pursuing her interest in global mental health, working as a group leader for refugees/asylum seekers in the Bellevue Survivors of Torture program, and the Association for Culture and Psychiatry.
She also became interested in models of Integrated Behavioral Health (IBH) to provide better access to mental health services within primary care and other settings. She founded the Integrated Behavioral Health resident working group and designed a two-year resident training program in the Collaborative Care Model, and developed a Collaborative Care model in one of NYU Langone-Brooklyn's FQHC sites. She completed residency as a chief resident and won awards for Excellence in Resident Teaching as well as for humanism and clinical excellence in the Comprehensive Psychiatric Emergency Program
Dr. Zein completed her Consult Liaison Fellowship at Stanford and has remained as clinical faculty. She previously currently served as an attending psychiatrist on the General, Intensive Care, and ED-Psychiatry Consult service. She currently works as the Psychiatric Director for Integrated Behavioral Health. She initially the model for the Stanford Primary Care Clinic serving Cisco employees and their families. She is currently working on expanding Integrated Behavioral health to other Stanford Primary Care Clinics, and has worked with Stanford's Digital Health Team to start and expand psychiatry e-consults for primary care. She also works as the Behavioral Health Director for Cisco, applying principles of organizational psychiatry and public health to assess company behavioral health strategy and provide support for Cisco employees and their families. Additionally, Dr Zein is part of the Stanford Mental Health lab where she supervises and completes evaluations for refugee and asylum seekers, and teaches Neuroscience and Psychopharmacology for the Psychiatry Residents -
Huaiyu Zhang
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor (By courtesy), Psychiatry and Behavioral SciencesBioDr. Zhang obtained her MS in Neuroscience from the University of Southern California and earned her PhD in Clinical Psychology from Emory University. She completed both her predoctoral internship and postdoctoral fellowship at Emory University School of Medicine. Prior to joining Stanford in 2023, Dr. Zhang supported survivors of interpersonal violence at the University of California San Francisco Trauma Recovery Center for over seven years. Dr. Zhang embraces an integrative, contextualized, evidence-informed, and strength-based approach to teaching, supervision, and clinical care. She provides services in English and Mandarin.
-
Mengrui Zhang
Senior Biostatistician, Med/Quantitative Sciences Unit
BioMengrui’s research focuses on leveraging advanced statistical and machine-learning techniques to extract meaningful insights from complex biological datasets. His research interests include bioinformatics, deep learning/machine learning, statistical testing, high-dimensional data, non-parametric modeling, time series analysis, and spatial statistics. Additionally, he is also interested in developing new methods, tools, and pipelines for various kinds of biological datasets, especially in single cell, RNA-Seq, metagenomics, and proteomics to support drug discovery and development.
-
Sha Zhang
Research Administrator, Medicine - Med/Immunology & Rheumatology
Current Role at StanfordFinancial Analyst
-
Tian Yi Zhang, MD, PhD
Assistant Professor of Medicine (Hematology)
BioDr. Zhang is a board-certified hematologist. She is also an assistant professor of hematology at Stanford University School of Medicine. In addition to her medical degree, she holds a PhD in cellular and molecular immunology.
In her clinical practice, she treats patients with all forms of hematological malignancies, offering specialized expertise in acute myeloid leukemia, including therapy-resistant cases. For each patient, she develops a personalized care plan encompassing novel treatment options.
Her research activities include conducting early phase clinical trials, investigator initiated clinical trials (IITs), studying the immune repertoire in patients with myeloid malignancies, and exploring cholesterol metabolic dependencies of acute myeloid leukemia (AML).
She was the recipient of an A.P. Giannini Foundation fellowship award, which supports innovative research. The award helped fund Dr. Zhang’s study of how AML cells interact with other cells in bone marrow. A significant finding confirmed that AML cells secrete a protein that suppresses the production of red blood cells, the same protein that causes inflammation in disorders such as rheumatoid arthritis and Crohn’s disease.
Her many other honors include the National Cancer Institute Career Development (K08) Award, the American Society of Hematology (ASH) Research Training Award for Fellows, Stanford Cancer Institute - American Cancer Society (SCI-ACS) Pilot Grant and Best ASH Abstract Award two years in a row. She also has earned recognition from the National Institutes of Health and American College of Physicians.
She has published her research findings on topics such as advanced therapy for high-risk myelodysplastic syndromes and reversal of bone marrow failure induced by AML. Her work has appeared in Leukemia & Lymphoma, Science Translational Medicine, Cancer Research, the Journal of Clinical Investigation, Journal of Immunology, and elsewhere.
Dr. Zhang is a member of the American Association of Cancer Research and American Society of Hematology. She advises and mentors Stanford medical students, residents and fellows. She delivers invited lectures to faculty and fellows. In addition, she has been an invited speaker on the topic of acute myeloid leukemia at the Association of Northern California Oncologists Update on Hematological Malignancies. -
Yuan Zhang
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioYuan Zhang, MD is a board certified family physician who enjoys providing both pediatric and adult care in disease screening, prevention, diagnosis, and treatment, including performing common office procedures. She has special interests in preventative medicine, women's health, and pediatric and adolescent health. She firmly believes that continued clinical excellence is rooted in lifelong learning - both from up-to-date clinical guidelines and from the lived experiences of her patients. She strives to deliver evidence-based care that is also compassionate and patient-centered.
-
Hong Zheng
Research Engineer, Med/BMIR-ITI Institute
BioMy research focuses on understanding the multi-omic landscape (genomics, epigenomics, transcriptomics, etc.) and immune responses in human diseases (cancer, aging, and infectious diseases, etc.), and identifying robust gene signatures and targets for disease diagnostics, prognostics, and therapeutics.
-
Jiayan Zhou
Affiliate, Medicine - Med/Cardiovascular Medicine
BioI am a Senior Computational Genomics Scientist at the Palo Alto Veterans Institute for Research (PAVIR) and was previously a Postdoctoral Scholar leading the identification of genes responsible for cardiovascular disease in the Division of Cardiovascular Medicine, School of Medicine, Stanford University, and the VA Palo Alto Health Care System. My research focuses on population genetics and precision public health.
-
Maggie Zhou
Instructor, Medicine - Oncology
BioDr. Zhou is an Instructor in the Division of Oncology at Stanford University with an academic focus in sarcoma. She graduated from Yale University with a B.A. and double majored in economics and molecular, cellular, and developmental biology. She subsequently received her M.D. from Stanford University School of Medicine, where she completed her internal medicine residency and fellowship training.
Her research interests center around the development of novel therapeutics, understanding pathophysiology of rare sarcoma subtypes, and evaluating the utility of circulating tumor DNA for assessing disease response and detecting minimal residual disease. She has co-authored over 20 peer-reviewed publications, including in Clinical Cancer Research and Nature Cell, and is an active member of the Sarcoma Clinical Trial Working Group in the Hoosier Cancer Research Network. Her research has been supported by the Chinese American Hematologist and Oncologist Network and Sarcoma Alliance for Research through Collaboration. -
Margaret J. Zhou, MD, MS
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Margaret Zhou is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. She also holds an appointment as clinical assistant professor at Stanford University School of Medicine.
She specializes in therapeutic endoscopy with expertise in treating Barrett’s esophagus and disorders of the pancreas and bile duct. In particular, she offers advanced endoscopic interventions to prevent, detect, and manage gastrointestinal (GI) cancers. These interventions include endoscopic mucosal resection, endoscopic ablation, endoscopic retrograde cholangiopancreatography, and endoscopic ultrasound. She is also interested in the management of esophageal disorders such as gastroesophageal reflux disease.
Dr. Zhou has published widely on improving the detection of precancerous lesions and cancers of the GI tract. She is particularly interested in prevention, early detection, and outcomes in Barrett’s esophagus, esophageal cancer, and stomach cancer. In addition, she has published on new technologies and the use of artificial intelligence in GI. Her research has been published in multiple journals including Clinical Gastroenterology and Hepatology; Clinical and Translational Gastroenterology; and Cancer Epidemiology, Biomarkers & Prevention.
Dr. Zhou is an active member of multiple national GI societies. She currently serves on the American Gastroenterological Association (AGA) Clinical Guidelines Committee and AGA Trainee and Early Career Committee. She also serves as an Associate Editor for Evidence-Based GI, an American College of Gastroenterology (ACG) journal. -
Han Zhu
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Zhu is an Assistant Professor of Medicine whose clinical and research expertise focuses on cardio-oncology and cardio-immunology. She specializes in the cardiovascular care of patients undergoing therapies for cancer, with a particular focus on the effects of immunotherapies on the heart. She received a bioengineering degree from MIT, medical degree from Case Western Reserve University, and completed clinical cardiology fellowship and internal medicine residency training at Stanford University School of Medicine. Dr. Zhu’s laboratory focuses on myocarditis, cardiac inflammation, and the effects of cancer therapeutics on the cardiovascular system. Her current research employs clinical data, bio-banked samples, and in vivo/in vitro preclinical models in combination with single-cell technologies to study immune-based toxicities in the heart. Dr. Zhu's clinic sees cardio-oncology and cardio-immunology patients and her lab focuses on devising new methods for minimizing cardiovascular complications in the cancer and autoimmune patient populations.
